In light of these studies, as MYC plays such an integral and important role in cancer, and given its involvement in SWI/SNF signaling, it would be interesting to explore more broadly the ability of direct or indirect targeting of SWI/SNF complex subunits regulating MYC to potentiate the therapeutic effects of IMiDs for MM. Here, SMARCA1 is linked to cancer.